- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00658710
Impact of Prolonged Physical Therapy on Gait Performance of Chronic Phase Stroke Patients (HEMIMARCHE)
November 6, 2013 updated by: Centre Hospitalier Universitaire de Saint Etienne
The aim of this multi-center, randomized controlled study is to acquire and compare information on gait performance in patients with chronic hemiplegia (six months to two years post-stroke) who either continue to attend two physical therapy sessions per week for two months or who stop physical therapy sessions for two months.Following the initial screening, subjects will be randomized into two groups: one who continues attending two physical therapy sessions per week for two months, or the other one who stops physical therapy sessions for two months.
Before and after those two months, a 3 days recording will be made using an ambulatory system called TRIDENT.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The aim of this multi-center, randomized controlled study is to acquire and compare information on gait performance in patients with chronic hemiplegia (six months to two years post-stroke) who either continue to attend two physical therapy sessions per week for two months or who stop physical therapy sessions for two months.
This will permit us 1) to assess the efficacy of continuing physical therapy sessions during the chronic phase of post-stroke hemiplegia, 2) to investigate whether the effects of physical therapy in these patients gradually decreases during the period of six months to two years post-stroke, and 3) to model the relationship between standard measures of gait performance (speed, endurance, balance, use of technical aids…) with other multidimensional covariates: social and environmental factors (type of housing, presence of a third person,…), cognitive factors (cognitive disorders associated) and thymic factors (anxiety, depression) and 4) to assess the costs associated with the physical therapy care of chronic-phase stroke patients .
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France, 49103
- Centre Régional de Réeducation et de Réadaptation Fonctionnelle
-
Bordeaux, France, 33076
- Groupe hospitalier Pellegrin CHU Bordeaux
-
Limoges, France, 87042
- Hôpital J. Rebeyrol
-
Nancy, France, 54042
- Institut Régional de Médecine Physique et de Réadaptation
-
St Etienne, France, 42055
- CHU de St Etienne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients must be aged 18 to 75 years, with a first ischemic or hemorrhagic stroke at least six months ago and no longer than two years ago, without subsequent stroke. It must have caused initially complete hemiplegia of the right or left hemibody, but they must be able of walk alone with or without technical assistance over a distance of at least 10 meters They must be able change direction too.
- Finally, they must have a Functional Ambulation Classification (FAC) score between 4 and 6 during the inclusion.
Exclusion Criteria:
- We will exclude patients with a neurological history other than a stroke, a psychiatric illness, or an associated debilitating disease.
- They must not have an associated cerebella syndrome or a clinical brainstem attack.
- We will refuse patients who are pregnant, who have not signed the written consent, and who aren't entitled to a social security scheme.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
patients who continue physical therapy sessions during two months.
|
two physical therapy sessions per week for two months
|
|
No Intervention: 2
patients who stop physical therapy sessions during two months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the average number of steps per day recorded over 3 days in an outpatient setting
Time Frame: day 3 and then 6 months later
|
day 3 and then 6 months later
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
the scores to the scales (the 6 minutes walking test, the Wade's test, the Rivermead Mobility Index Score, the Barthel Index Score)
Time Frame: day 0 and then day 55
|
day 0 and then day 55
|
|
for the medico-economic study, the direct medical and non-medical costs associated with physical therapy of chronic stroke patients
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Pascal Giraux, MD, CHU St Etienne
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
April 11, 2008
First Submitted That Met QC Criteria
April 14, 2008
First Posted (Estimate)
April 15, 2008
Study Record Updates
Last Update Posted (Estimate)
November 7, 2013
Last Update Submitted That Met QC Criteria
November 6, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0701040
- 2007-A00747-46
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.